BioNTech SE (XTER:22UA)
€ 104.5 5.1 (5.13%) Market Cap: 24.57 Bil Enterprise Value: 8.11 Bil PE Ratio: 0 PB Ratio: 1.25 GF Score: 67/100

Q4 2020 BioNTech SE Earnings Call Transcript

Mar 30, 2021 / 12:00PM GMT
Release Date Price: €87.8 (+9.44%)
Operator

Good day, and thank you for standing by. Welcome to BioNTech's Corporate Update and Financial Results Fourth Quarter and Full Year 2020 Conference Call. (Operator Instructions) Please be advised today's conference is being recorded. (Operator Instructions)

Now I'd like to hand the conference over to your first speaker today, Sylke Maas, Vice President, Investor Relations and Strategy. Please go ahead.

Sylke Maas
BioNTech SE - VP of IR and Business Strategy

Thank you. Good morning and good afternoon. Thank you for joining us today to review BioNTech's fourth quarter and full year 2020 operational progress and financial results. Before we start, we encourage you to view the slides for this webcast as well as the operational and financial results press release issued this morning, both of which are accessible on our website in the Investors section.

As shown on Slide 2, during today's presentation, we will be making several forward-looking statements. These forward-looking statements include but are not limited to our current estimate of COVID

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot